OAM
RVMD icon

OP Asset Management’s Revolution Medicines RVMD Stock Holding History

OP Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Sell
22,941
-10,692
-32% -$1.56M 0.05% 289
2026
Q1 		$3.27M Buy
+33,633
New +$3.4M 0.03% 337
2025
Q4 		– Sell
-5,242
Closed -$245K – 827
2025
Q3 		$245K Hold
5,242
– – ﹤0.01% 726
2025
Q2 		$193K Sell
5,242
-3,108
-37% -$119K ﹤0.01% 744
2025
Q1 		$295K Buy
+8,350
New +$339K ﹤0.01% 733

Other funds holding RVMD

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

OP Asset Management's RVMD Position: Q2 2026 in Review

OP Asset Management reduced its Revolution Medicines (RVMD) stake by 32% in Q2 2026, selling an estimated $1.56M and leaving 22,941 shares worth $4.3M. The position accounts for 0.05% of the portfolio, ranked #289.

OP Asset Management first reported a position in RVMD in Q1 2025 and has held it in 5 quarters since. 199 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • OP Asset Management held 22,941 shares of Revolution Medicines worth $4.3M as of Q2 2026.
  • OP Asset Management sold 10,692 Revolution Medicines shares in Q2 2026, an estimated $1.56M.
  • Revolution Medicines made up 0.05% of OP Asset Management's portfolio in Q2 2026, its #289 holding.
  • OP Asset Management first reported a position in Revolution Medicines in Q1 2025 and has held it in 5 quarters since.
  • 199 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.